See inside every stock. Pro
S&P 5007,624▼ 0.52%Nasdaq25,955▼ 0.21%Dow Jones52,215▼ 1.23%Nasdaq 10028,958▼ 0.00%VIX19.45▲ 2.21%US Dollar101.75▲ 0.14%Gold spot4,012▼ 0.30%WTI103.27▲ 3.82%
← ALMLB page
XStocksXray
Market X-Ray report · 23 October 2026

Miliboo SA (ALMLB)

Euronext Paris · France · prices in EUR · close of 23 Oct 2026

Key indicators

Last closeEUR 1.610
52-week range1.440 – 2.200
Return, 1 month / 3 months−4.7% / −1.8%
Return, 1 year / 3 years−3.6% / −6.9%
TrendBelow its 200-day average
RSI (14)47
Volatility (1 year)54.8%
Worst drawdown (1 year)-32.1%
Average daily value traded0.00M EUR
Dividend yield–

Market X-Ray price-based

48/ 100 · High confidence · ahead of 44% of stocks on this exchange
Trend53
Momentum63
Stability (higher is calmer)45
Liquidity22
Income–

Five-year price chart navy: price · brown: 200-day average

0.872.173.474.766.062021-112023-022024-052025-082026-10

About the company

Miliboo is a French furniture company that designs and sells its own-brand home furnishings, with a focus on sofas, armchairs and other seating, directly to households through its online store. It also offers related living-room and bedroom pieces, and it handles design, sourcing and delivery for customers across France and other European markets. The company is based in Annecy-le-Vieux, in the Haute-Savoie area of France, and serves individual consumers rather than trade buyers.

On this site Miliboo SA appears as a stock on the Euronext Paris (France), code ALMLB, with prices in euros (EUR). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Miliboo SA (ALMLB) trades on the Euronext Paris in France. It last closed at EUR 1.610 on 23 October 2026.

Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 349 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 3.6% and over the last three months it fell 1.8%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Miliboo SA (ALMLB)

The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris

Lens and metricValueScoreReading
Trend53 · FairMixed trend against its averages.
Above 200-day average-5.4%
From 52-week high-26.1%
Momentum63 · FairTypical recent returns for this exchange.
3-month return-1.8%
6-month return-3.6%
12-month return, skipping the last month1.2%
Stability (higher is calmer)45 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)54.8%
Worst drawdown, 1 year (smaller is calmer)-32.1%
Liquidity22 · WeakThinly traded: prices can jump and exits can be hard.
Average daily value traded0.00M EUR
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.
  • Liquidity: Thinly traded: prices can jump and exits can be hard.

Returns

1 week−10.6%
1 month−4.7%
3 months−1.8%
6 months−3.6%
1 year−3.6%
3 years−6.9%
5 years−69.9%

Signals

50-day / 200-day average1.619 / 1.703
Golden / death cross (60 days)Death, 44 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.064

Technical summary

DailyBearish2 bullish · 4 neutral · 10 bearish
WeeklyStrongly bearish1 bullish · 1 neutral · 10 bearish
MonthlyBearish2 bullish · 1 neutral · 5 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 24 Oct 2026